Article may be outdated

This article is 86 days old. Some details may have changed since publication.

Headlinne
Sign inGet Headlinne
TechCrunch·3 min read·medium

H1 secures $40M from CVS, proving SaaS startups can still attract investment

M
Marina Temkin
H1 secures $40M from CVS, proving SaaS startups can still attract investment
✦AI Summary

Healthcare data platform H1 has secured $40 million in funding led by CVS Health Ventures, despite a broader market trend favoring AI-focused startups. CEO Ariel Katz argues that data-centric SaaS companies remain valuable because their proprietary information is difficult for AI models to replicate.

Why it matters

This investment suggests that established SaaS companies with strong data moats can still attract capital even as investor interest shifts heavily toward generative AI.

✦Dive DeeperCreate a free account to unlock

H1 secures $40M from CVS, proving SaaS startups can still attract investment | TechCrunch

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
businessstartupshealth
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 80%

The article presents the company's perspective while acknowledging it is self-serving, maintaining a balanced business reporting tone.

Read originalGet full access
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in